产品中心 蛋白翻译后修饰(PTM)抗体 位点特异性修饰抗体

所有图片(1/4)

Histone H3 (Crotonyl K9) Recombinant Rabbit mAb (S-R409)

H3K9Cr

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B0879
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    Histone H3 (Crotonyl K9)
  • 分子别名

    H3K9Cr
  • 细胞定位

    Nucleus
  • Accession

    P68431
  • 克隆号

    S-R409
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 翻译后修饰类型

    巴豆酰化
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    1 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    ChIP

    ICC ?

    WB

    IP

  • 稀释度

    应用 稀释度
    WB 1:500-1:1000
    IP 1:100
    ICC 1:1000
    ChIP 1:20-1:50
背景介绍
  • Histone H3 crotonylation, specifically at lysine 9 (H3K9cr), is a form of post-translational modification that has been identified as a key player in epigenetic regulation, particularly in plants 。This modification is structurally and functionally distinct from the well-studied lysine acetylation and is involved in various biological processes, including chromatin remodeling, metabolism, cell cycle, and cellular organization. In the context of histones, crotonylation can be found on different lysine residues among plant species and is known to overlap with the histone modification H3K9ac in about 95% of the regions, which suggests a potential interplay between these two modifications.

  • 免疫印迹

    • WB result of Histone H3 (Crotonyl K9) Recombinant Rabbit mAb
      Primary antibody: Histone H3 (Crotonyl K9) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated HeLa whole cell lysate 20 µg
      Lane 2: HeLa treated with 500 ng/ml TSA for 4 hours whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 15 kDa
      Observed MW: 17 kDa
      This blot was developed with high sensitivity substrate

  • 免疫沉淀

    • Histone H3 (Crotonyl K9) Rabbit mAb at 1/100 dilution (1 µg) immunoprecipitating Histone H3 (Crotonyl K9) in 0.4 mg HeLa treated with 500 ng/ml TSA for 4 hours whole cell lysate.
      Western blot was performed on the immunoprecipitate using Histone H3 (Crotonyl K9) Rabbit mAb at 1/1000 dilution.
      Secondary antibody (HRP) for IP was used at 1/1000 dilution.
      Lane 1: HeLa treated with 500 ng/ml TSA for 4 hours whole cell lysate 20 µg (Input)
      Lane 2: Histone H3 (Crotonyl K9) Rabbit mAb IP in HeLa treated with 500 ng/ml TSA for 4 hours whole cell lysate
      Lane 3: Rabbit monoclonal IgG IP in HeLa treated with 500 ng/ml TSA for 4 hours whole cell lysate
      Predicted MW: 15 kDa
      Observed MW: 17 kDa
      This blot was developed with high sensitivity substrate

  • 免疫细胞化学

    • ICC analysis of HeLa cells treated with TSA (500ng/ml,4h) (top panel) and HeLa cells untreated with TSA (500ng/ml,4h) (below panel). Anti-Histone H3 (Crotonyl K9) antibody was used at 1/1000 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

  • ChIP

    • Chromatin immunoprecipitation (ChIP) was performed on HeLa+TSA (500ng/ml,4h) cells cross - linked with 1% formaldehyde for 10 min, then chromatin was fragmented by sonication. Parallel reactions used Histone H3 (Crotonyl K9) Recombinant Rabbit mAb (S-R409) and Rabbit mAb IgG Isotype Control (SDT-R173) only at 1:20 for immunoprecipitation.
      Post -immunoprecipitation, both samples were washed, eluted, and cross - links reversed. Purified DNA was analyzed by qPCR.
      qPCR (%input: immunoprecipitated DNA/input DNA)
      showed the enrichment of RPL30, GAPDH, MYOD1,
      AFM, SAT-α and SAT-2 in Histone H3 (Crotonyl K9)
      Recombinant Rabbit mAb (S-R409)-immunoprecipitated
      sample.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)